Elisa Habermann

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander Ten Hagen, Elisa Habermann, Florian Kurth, Leif-Erik Sander, Victor Max Corman, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach, Jens Klotsche
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. RMD open 8 (2) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd-Rüdiger R Burmester, Robert Biesen, Fredrik Nils Albach
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series. RMD open 8 (2) (2023)
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander Ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif-Erik Sander, Gerd-Rüdiger R Burmester, Florian Klein, Robert Biesen
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination. RMD open 8 (2) (2022)